F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on medical record review, hospital documentation review, staff interview, and review of a facility
policy, the facility failed ensure medications were available to administer as ordered. This affected one (#13)
of three residents received for medication administration. The census was 54.
Findings Included:
Review of Resident #13's medical record revealed an admission date of 12/15/24. Diagnoses included
chronic obstructive pulmonary disease, asthma, diabetes mellitus type II, atrial fibrillation, and bipolar
disorder.
Review of a hospital discharge document dated 12/15/24 revealed Resident #13 had a medication order for
the decongestant guaifenesin 600 mg one tablet every 12 hours.
Review of a physician order dated 12/17/24 revealed Resident #13 was ordered guaifenesin extended
release 600 mg one tablet twice daily for cough for seven days.
Review of a nursing progress note dated 12/17/24 by Registered Nurse (RN) #219 revealed Resident #13's
guaifenesin 600 mg extended release tablet twice a day for seven days for cough was on order.
Review of Resident #13's December 2024 medication administration record (MAR) revealed the resident
received the first dose of guaifenesin on 12/18/24 at 9:00 A.M.
Interview on 12/30/24 at 4:00 P.M. with Assistant Director of Nursing (ADON) #262 verified Resident #13
missed doses of the ordered guaifenesin 600 extended release tablets and did not received the first dose
until 12/17/24.
Review of a facility policy titled, Medication Administration, dated 2024, revealed medications are
administered by licensed nurses as ordered by the physician and in accordance with professional
standards of practice, in a manner to prevent contamination or infection.
This deficiency represents non-compliance investigated under Master Complaint Number OH00161089 and
Complaint Number OH00160325.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
365789
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365789
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/30/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Sanctuary at Wilmington Place
264 Wilmington Avenue
Dayton, OH 45420
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
Based on medical record review, hospital documentation review, resident and staff interview, review of a
photograph of a medication package, review of a contingent medication inventory list, and review of a
facility policy, the facility failed to ensure medications were administered as ordered to prevent significant
medication errors. This affected one (#13) of three residents reviewed for medication administration. The
facility census was 54.
Residents Affected - Few
Findings Included:
Review of Resident #13's medical record revealed an admission date of 12/15/24. Diagnoses included
chronic obstructive pulmonary disease, asthma, diabetes mellitus type II, atrial fibrillation, and bipolar
disorder.
Review of a hospital discharge document dated 12/15/24 revealed Resident #13 had medication orders for
the diuretic furosemide 20 milligrams (mg) by mouth once a day and the steroid Medrol dose package
(pack) four (4) mg with instructions to follow the dose pack.
Review of physician orders dated 12/16/24 revealed Resident #13 was ordered Medrol 4 mg two (2) tablets
in the morning scheduled for 9:00 A.M., 2 tablets by mouth at 2:00 P.M., 2 tablets by mouth at 6:00 P.M., 2
tablets by mouth at 8:00 P.M., and 2 tablets by mouth at 9:00 P.M. Review of a physician order dated
12/28/24 revealed Resident #13 was ordered Medrol 4 mg once daily until 12/30/24. Review of physician
orders dated 12/30/24 revealed Resident #13 was ordered Medrol 4 mg once daily at 3:00 P.M. and 6:00
P.M.
Review of a physician order dated 12/17/24 revealed Resident #13 was ordered furosemide 20 mg daily.
Review of Resident #13's December 2024 medication administration record (MAR) revealed Resident #13's
Medrol 4 mg was administered on 12/16/24 at 2:00 P.M., 6:00 P.M., 8:00 P.M., and 9:00 P.M.; on 12/28/24 at
6:00 A.M.; on 12/29/24 at 6:00 A.M.; and on 12/30/24 at 6:00 A.M. and 3:00 P.M. Further review of the
December 2024 MAR revealed Resident #13 received furosemide 20 mg on 12/18/24 at 9:00 A.M.
Interview on 12/30/24 at 2:36 P.M. with Resident #13 stated she did not receive her medications for several
days after she was admitted to the facility.
Interview on 12/30/24 at 4:00 P.M. with Assistant Director of Nursing (ADON) #262 verified Resident #13
missed doses of furosemide 20 mg and was not administered Medrol 4 mg correctly per physician order.
ADON #262 verified furosemide 20 mg was in stock in the facility contingency medication supply and
should have been pulled by the nurse.
Review of photograph of a Medrol 4 mg medication pack, supplied by the facility on 12/31/24, revealed on
the first day to take 2 tablets before breakfast, one tablet after lunch, and one tablet after supper, and two
tablets at bedtime. The pack instructions continued on the second day take one tablet before breakfast, one
tablet after lunch, one tablet after supper, and two tablets at bedtime. On the third day, take one tablet
before breakfast, one tablet after lunch, one tablet after supper, and one tablet at bedtime. On the fourth
day, take one tablet before breakfast, one tablet after lunch, and one tablet at bedtime. On the fifth day, take
one tablet before breakfast, and one tablet at
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365789
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365789
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/30/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Sanctuary at Wilmington Place
264 Wilmington Avenue
Dayton, OH 45420
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
bedtime. On the sixth day, take one tablet before breakfast. Further review revealed eight Medrol 4 mg
tablets were removed from the pack and 13 tablets remained not administered.
Interview on 12/31/24 at 3:13 P.M. with Administrator confirmed the photograph of the Medrol 4 mg pack
was Resident #13's medication that was left and not administered.
Residents Affected - Few
Review of facility document titled, Inventory on Hand, dated 12/30/24, revealed 16 furosemide 20 mg
tablets were on hand at the facility stock.
Review of the facility policy titled, Medication Administration, dated 2024, revealed medication are
administered by licensed nurses as ordered by the physician and in accordance with professional
standards of practice, in a manner to prevent contamination or infection. Medications are to be administered
as ordered in accordance with manufacturer specifications.
This deficiency represents non-compliance investigated under Master Complaint Number OH00161089 and
Complaint Number OH00160325.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365789
If continuation sheet
Page 3 of 3